Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4662805 | 0.92 | ACP3 (0.41) | ACP3ACHEAOC3CYP19A1TRPA1 | |
| SCHEMBL27453900 | 0.83 | ACHE (0.46) | ACP3ACHEAOC3CYP19A1SLC6A2 | |
| SCHEMBL3196398 | 0.82 | ACP3 (0.42) | ACP3ACHEAOC3CYP19A1TRPA1 | |
| SCHEMBL10409370 | 0.82 | TRPA1 (0.46) | ACP3ACHEAOC3CYP19A1TRPA1 | |
| SCHEMBL24527613 | 0.82 | AOC3 (0.42) | ACP3ACHEAOC3CYP19A1TRPA1 | |
| SCHEMBL28830485 | 0.82 | ACP3 (0.39) | ACP3ACHEAOC3CYP19A1SLC6A2 | |
| SCHEMBL28830483 | 0.82 | ACP3 (0.39) | ACP3ACHEAOC3CYP19A1SLC6A2 | |
| SCHEMBL29800155 | 0.82 | ACP3 (0.39) | ACP3ACHEAOC3CYP19A1SLC6A2 | |
| Toluene SCHEMBL8820915 | 0.82 | TRPA1 (0.48) | ACP3ACHETRPA1LMNAALOX12 | |
| Toluene SCHEMBL9044191 | 0.82 | TRPA1 (0.48) | ACP3ACHETRPA1LMNAALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2042532-B1 | Polymerizable composition and planographic printing plate precursor using the same, alkalisoluble polyurethane resin, and process for producing diol compound | FUJIFILM CORP (JP) | 2011-09-14 | — | — | EP | disclosed |
| US-7741011-B2 | Polymerizable composition and planographic printing plate precursor using the same, alkali-soluble polyurethane resin, and process for producing diol compound | FUJIFILM CORPORATION (JP) | 2010-06-22 | — | — | US | disclosed |
| US-20090087785-A1 | POLYMERIZABLE COMPOSITION AND PLANOGRAPHIC PRINTING PLATE PRECURSOR USING THE SAME, ALKALI-SOLUBLE POLYURETHANE RESIN, AND PROCESS FOR PRODUCING DIOL COMPOUND | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| EP-2042532-A2 | Polymerizable composition and planographic printing plate precursor using the same, alkalisoluble polyrethane resin, an process for producing diol compound | FUJIFILM Corporation (JP) | 2009-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087785-A1 | POLYMERIZABLE COMPOSITION AND PLANOGRAPHIC PRINTING PLATE PRECURSOR USING THE SAME, ALKALI-SOLUBLE POLYURETHANE RESIN, AND PROCESS FOR PRODUCING DIOL COMPOUND | PAH, RPN1, RER1 | ACP3 3034/4885ACHE 4843/4885AOC3 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.